Fototerapia en combinación con otras terapias en psoriasis
DOI:
https://doi.org/10.29176/2590843X.290Palabras clave:
psoriasis, fototerapia, retinoides, metotrexato, productos biológicosResumen
La psoriasis es una enfermedad crónica inflamatoria, multifactorial, que afecta del 1 al 3 % de la población mundial. Para su tratamiento se ha descrito un sinnúmero de esquemas terapéuticos, entre los cuales se encuentran los tratamientos tópicos combinados para la psoriasis leve a moderada, mientras que la psoriasis grave requiere un manejo más completo con fototerapia y tratamientos sistémicos, como retinoides orales, metotrexato, ciclosporina y medicamentos biológicos. Aunque muchos datos apoyan la eficacia de la fototerapia en el tratamiento de la psoriasis, aún hay gran variabilidad en su aplicación en todo el mundo y cada vez más se apoya el concepto de tratamientos combinados, los cuales pueden aumentar la eficacia y la tolerabilidad, e inclusive, pueden disminuir los efectos secundarios de ciertos medicamentos aumentando el perfil de seguridad del tratamiento. Sin embargo, a pesar de lo anterior, la manera como la fototerapia ha encajado en el uso combinado con otros agentes, tópicos o sistémicos, apenas está siendo dilucidada.
Biografía del autor/a
Lina Tatiana Acosta, Universidad CES
Médica, residente de Dermatología, Universidad CES, Medellín, Colombia
Claudia Marcela Gaviria, Universidad CES
Médica, residente de Dermatología, Universidad CES, Medellín, Colombia
Ana Paula Giraldo, Universidad CES
Médica, residente de Dermatología, Universidad CES, Medellín, Colombia
Juliana Mariaca, Universidad Pontificia Bolivariana
Médica, residente de Dermatología, Universidad Pontificia Bolivariana, Medellín, Colombia
Melisa Montes, Universidad Pontificia Bolivariana
Médica, residente de Dermatología, Universidad Pontificia Bolivariana, Medellín, Colombia
Sol Beatriz Jiménez, Universidad CES
Médica dermatóloga; jefe, Servicio de Dermatología, Grupo Dermatología CES, Universidad CES, Medellín, Colombia
Referencias bibliográficas
1. Calle J, Rivas AM, Ruiz MC. Manejo de la psoriasis con luz ultravioleta A más psolareno (PUVA) y luz ultravioleta B (UVB). Rev Asoc Col Dermatol. 2009;17:162-71.
2. Sbidian E, Maza A, Montaudié H, Gallini A, Aractingi S, Aubin F, et al. Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review. J Eur Acad Dermatol Venereol. 2011;25(Suppl.2):28-33.
3. Lee CS, Li K. A review of acitretin for the treatment of psoriasis. Expert Opin Drug Saf. 2009;8:769-79.
4. Lapolla W, Yentzer BA, Bagel J, Halvorson CR, Feldman SR. A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol. 2011;64:936-49.
5. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60:643-59.
6. Aaronson DS, Lebwohl M. Review of therapy of psoriasis: The prebiologic armamentarium. Dermatol Clin. 2004;22:379-88, viii.
7. González C, Londoño A, Gómez L. Guías basadas en la evidencia para el manejo de la psoriasis en Colombia. Bogotá: Panamericana Formas e Impresos; 2012.
8. Morison WL, Parrish JA, Fitzpatrick TB. Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis. Br J Dermatol. 1978;98:125-32.
9. Schmoll M, Henseler T, Christophers E. Evaluation of PUVA, topical corticosteroids and the combination of both in the treatment of psoriasis. Br J Dermatol. 1978;99:693-702.
10. Meola T, Soter NA, Lim HW. Are topical corticosteroids useful adjunctive therapy for the treatment of psoriasis with ultraviolet radiation? A review of the literature. Arch Dermatol. 1991;127:1708-13.
11. Lebwohl M, Menter A, Koo J, Feldman SR. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol. 2004;50:416-30.
12. Carrascosa JM, López-Estebaranz JL, Carretero G, Daudén E, Ferrándiz C, Vidal D, et al. Narrowband UV-B, monochromatic excimer laser, and photodynamic therapy in psoriasis: A consensus statement of the Spanish Psoriasis Group. Actas Dermosifiliogr. 2011;102:175-86.
13. Penven K, Leroy D, Verneuil L, Faguer K, Dompmartin A. Evaluation of vaseline oil applied prior to UVB TL01 phototherapy in the treatment of psoriasis. Photodermatol Photoimmunol Photomed. 2005;21:138-41.
14. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol. 2010;62:114-35.
15. Bagel J. LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone. J Drugs Dermatol. 2009;8:351-7.
16. Jain VK, Jangra S, Aggarwal K. Comparative efficacy of narrow-band ultraviolet B phototherapy alone and its combination with topical 8-methoxypsoralen in psoriasis. Indian J Dermatol Venereol Leprol. 2010;76:666-70.
17. Thaçi D, Salgo R. Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: Facts and controversies. Clin Dermatol. 2010;28:52-6.
18. Kokelj F, Plozzer C, Torsello P. Reduction of UV-A radiation induced by calcipotriol in the treatment of vulgar psoriasis with oral psoralen plus UV-A. Arch Dermatol. 1997;133:668-9.
19. Bailey EE, Ference EH, Alikhan A, Hession MT, Armstrong AW. Combination treatments for psoriasis: A systematic review and meta-analysis. Arch Dermatol. 2012;148:511-22.
20. Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CE. Combination regimens of topical calcipotriene in chronic plaque psoriasis: Systematic review of efficacy and tolerability. Arch Dermatol. 2000;136:1536-43.
21. Brands S, Brakman M, Bos JD, de Rie MA. No additional effect of calcipotriol ointment on low-dose narrow-band UVB phototherapy in psoriasis. J Am Acad Dermatol. 1999;41:991-5.
22. Adachi Y, Uchida N, Matsuo T, Horio T. Clinical effect of vitamin D3 analogues is not inactivated by subsequent UV exposure. Photodermatol Photoimmunol Photomed. 2008;24:16-8.
23. Guerra A. Novedades en el tratamiento tópico de la psoriasis. Med Cutan iber Lat Am. 2004;32:79-89.
24. Behrens S, Grundmann-Kollmann M, Peter RU, Kerscher M. Combination treatment of psoriasis with photochemotherapy and tazarotene gel, a receptor-selective topical retinoid. Br J Dermatol. 1999;141:177.
25. Tzaneva S, Hönigsmann H, Tanew A, Seeber A. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis. Br J Dermatol. 2002;147:748-53.
26. Koo JY, Lowe NJ, Lew-Kaya DA, Vasilopoulos AI, Lue JC, Sefton J, et al. Tazarotene plus UVB phototherapy in the treatment of psoriasis. J Am Acad Dermatol. 2000;43:821-8.
27. Guenther LC. Optimizing treatment with topical tazarotene. Am J Clin Dermatol. 2003;4:197-202.
28. Paul C, Gallini A, Archier E, Castela E, Devaux S, Aractingi S, et al. Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol. 2012;26(Suppl.3):1-10.
29. Schiener R, Behrens-Williams SC, Pillekamp H, Kaskel P, Peter RU, Kerscher M. Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): Efficacy in patients with severe psoriasis. Br J Dermatol. 2000;143:1275-8.
30. Rogers C. Calcipotriol (Dovobet) ointment in combination with UVB therapy for psoriasis treatment. Dermatol Nurs Dermatol Nurses Assoc. 2006;18:258-61.
31. Arechalde A, Saurat JH. Management of psoriasis: The position of retinoid drugs. BioDrugs Clin Immunother Biopharm Gene Ther. 2000;13(5):327-33. Encontré: BioDrugs. 2000;13:327-33.
32. Spuls PI, Rozenblit M, Lebwohl M. Retrospective study of the efficacy of narrowband UVB and acitretin. J Dermatol Treat. 2003;14(Suppl.2):17-20.
33. Ghasri P, Yentzer BA, Dabade TS, Feldman SR. Acitretin for the treatment of psoriasis: An assessment of national trends. J Drugs Dermatol. 2011;10:873-7.
34. Dunn LK, Gaar LR, Yentzer BA, O’Neill JL, Feldman SR. Acitretin in dermatology: A review. J Drugs Dermatol. 2011;10:772-82.
35. Hodulik SG, Zeichner JA. Combination therapy with acitretin for psoriasis. J Dermatol Treat. 2006;17:108-11.
36. Mortazavi H, Khezri S, Hosseini H, Khezri F, Vasigh M. A single blind randomized clinical study: The efficacy of isotretinoin plus narrow band ultraviolet B in the treatment of psoriasis vulgaris. Photodermatol Photoimmunol Photomed. 2011;27:159-61.
37. Ormerod AD, Campalani E, Goodfield MJD, BAD Clinical Standards Unit. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol. 2010;162:952-63.
38. De Mozzi P, Johnston GA, Alexandroff AB. Psoriasis: An evidence-based update. Br J Dermatol. 2012;166:252-60.
39. Patel RV, Clark LN, Lebwohl M, Weinberg JM. Treatments for psoriasis and the risk of malignancy. J Am Acad Dermatol. 2009;60:1001-17.
40. Warren RB, Griffiths CEM. Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine. Clin Dermatol. 2008;26:438-47.
41. Jensen P, Skov L, Zachariae C. Systemic combination treatment for psoriasis: A review. Acta Derm Venereol. 2010;90:341-9.
42. Shehzad T, Dar NR, Zakria M. Efficacy of concomitant use of PUVA and methotrexate in disease clearance time in plaque type psoriasis. J Pak Med Assoc. 2004;54:453-5.
43. Mahajan R, Kaur I, Kanwar AJ. Methotrexate/narrowband UVB phototherapy combination vs. narrowband UVB phototherapy in the treatment of chronic plaque-type psoriasis--a randomized single-blinded placebo-controlled study. J Eur Acad Dermatol Venereol. 2010;24:595-600.
44. Asawanonda P, Nateetongrungsak Y. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: A randomized, placebo-controlled study. J Am Acad Dermatol. 2006;54:1013-8.
45. Barrios M, Beltrán A, Catellanos H, Cortés C. Guías basadas en la evidencia para el manejo de la psoriasis en Colombia. Bogotá: Asociación Colombiana de Dermatología y Cirugía Dermatológica; 2012.
46. Chalela JG, González C, Castro L. Guías de manejo de psoriasis consenso colombiano. Bogotá: Asociación Colombiana de Dermatología y Cirugía Dermatológica; 2008.
47. Echeverri MA, Aristizábal AM, Vargas F, Molina JF, Pinto LF, Zuluaga Á. Nuevos avances de la terapia biológica en la psoriasis. Med Cutan Iber Lat Am. 2005;33:7-17.
48. Wolf P, Hofer A, Weger W, Posch-Fabian T, Gruber-Wackernagel A, Legat FJ. 311 nm ultraviolet B-accelerated response of psoriatic lesions in adalimumab-treated patients. Photodermatol Photoimmunol Photomed. 2011;27:186-9.
49. Bagel J. Adalimumab plus narrowband ultraviolet B light phototherapy for the treatment of moderate to severe psoriasis. J Drugs Dermatol. 2011;10:366-71.
50. Garber C, Creighton M, Sorensen E, Dumont N, Gottlieb AB. Systemic treatment of recalcitrant pediatric psoriasis: A case series and literature review. J Drugs Dermatol. 2015;14:881-6.
51. Famenini S, Wu JJ. Combination therapy with tumor necrosis factor inhibitors in psoriasis treatment. Cutis. 2013;92:140-7.
52. Scheinfeld N. Therapy resistant psoriasis treated with alefacept and subsecuent narrow band ultraviolet B phototherapy with total clearing of psoriasis. Dermatol Online J. 2005;11:7-11.
53. Koo J, Bagel J, Sweetser M, Ticho B. Alefacept in combination with ultraviolet B phototherapy for the treatment of chronic plaque psoriasis: Resulst from an open label, multicenter study. J Drugs Dermatol. 2006;5:623-8.
54. Bailey EE, Ference EH, Alikhan A, Hession MT, Armstrong AW. Combination treatments for psoriasis: A systematic review and meta-analysis. Arch Dermatol. 2012;148:511-22.
55. Menter A, Gottlieb A, Feldman SR, van Voorhees AS, Leonardi CL, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58:826-50.
56. Foley P, Quirk C, Sullivan J, Dolianitis C, Hack SP, Thirunavukkarasu K, et al. Combining etanercept with traditional agents in the treatment of psoriasis: A review of the clinical evidence. J Eur Acad Dermatol Venereol. 2010;24:1135-43.
57. Chien AL, Elder JT, Ellis CN. Ustekinumab. A new option in psoriasis therapy. Drugs. 2009;69:1141-52.
58. Wolf P, Weger W, Legat FJ, Posch-Fabian T, Gruber-Wackernagel A, Inzinger M, et al. Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: A randomized intraindividual trial. Br J Dermatol. 2012;166 :147-53.
2. Sbidian E, Maza A, Montaudié H, Gallini A, Aractingi S, Aubin F, et al. Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review. J Eur Acad Dermatol Venereol. 2011;25(Suppl.2):28-33.
3. Lee CS, Li K. A review of acitretin for the treatment of psoriasis. Expert Opin Drug Saf. 2009;8:769-79.
4. Lapolla W, Yentzer BA, Bagel J, Halvorson CR, Feldman SR. A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol. 2011;64:936-49.
5. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009;60:643-59.
6. Aaronson DS, Lebwohl M. Review of therapy of psoriasis: The prebiologic armamentarium. Dermatol Clin. 2004;22:379-88, viii.
7. González C, Londoño A, Gómez L. Guías basadas en la evidencia para el manejo de la psoriasis en Colombia. Bogotá: Panamericana Formas e Impresos; 2012.
8. Morison WL, Parrish JA, Fitzpatrick TB. Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis. Br J Dermatol. 1978;98:125-32.
9. Schmoll M, Henseler T, Christophers E. Evaluation of PUVA, topical corticosteroids and the combination of both in the treatment of psoriasis. Br J Dermatol. 1978;99:693-702.
10. Meola T, Soter NA, Lim HW. Are topical corticosteroids useful adjunctive therapy for the treatment of psoriasis with ultraviolet radiation? A review of the literature. Arch Dermatol. 1991;127:1708-13.
11. Lebwohl M, Menter A, Koo J, Feldman SR. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol. 2004;50:416-30.
12. Carrascosa JM, López-Estebaranz JL, Carretero G, Daudén E, Ferrándiz C, Vidal D, et al. Narrowband UV-B, monochromatic excimer laser, and photodynamic therapy in psoriasis: A consensus statement of the Spanish Psoriasis Group. Actas Dermosifiliogr. 2011;102:175-86.
13. Penven K, Leroy D, Verneuil L, Faguer K, Dompmartin A. Evaluation of vaseline oil applied prior to UVB TL01 phototherapy in the treatment of psoriasis. Photodermatol Photoimmunol Photomed. 2005;21:138-41.
14. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol. 2010;62:114-35.
15. Bagel J. LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone. J Drugs Dermatol. 2009;8:351-7.
16. Jain VK, Jangra S, Aggarwal K. Comparative efficacy of narrow-band ultraviolet B phototherapy alone and its combination with topical 8-methoxypsoralen in psoriasis. Indian J Dermatol Venereol Leprol. 2010;76:666-70.
17. Thaçi D, Salgo R. Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: Facts and controversies. Clin Dermatol. 2010;28:52-6.
18. Kokelj F, Plozzer C, Torsello P. Reduction of UV-A radiation induced by calcipotriol in the treatment of vulgar psoriasis with oral psoralen plus UV-A. Arch Dermatol. 1997;133:668-9.
19. Bailey EE, Ference EH, Alikhan A, Hession MT, Armstrong AW. Combination treatments for psoriasis: A systematic review and meta-analysis. Arch Dermatol. 2012;148:511-22.
20. Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CE. Combination regimens of topical calcipotriene in chronic plaque psoriasis: Systematic review of efficacy and tolerability. Arch Dermatol. 2000;136:1536-43.
21. Brands S, Brakman M, Bos JD, de Rie MA. No additional effect of calcipotriol ointment on low-dose narrow-band UVB phototherapy in psoriasis. J Am Acad Dermatol. 1999;41:991-5.
22. Adachi Y, Uchida N, Matsuo T, Horio T. Clinical effect of vitamin D3 analogues is not inactivated by subsequent UV exposure. Photodermatol Photoimmunol Photomed. 2008;24:16-8.
23. Guerra A. Novedades en el tratamiento tópico de la psoriasis. Med Cutan iber Lat Am. 2004;32:79-89.
24. Behrens S, Grundmann-Kollmann M, Peter RU, Kerscher M. Combination treatment of psoriasis with photochemotherapy and tazarotene gel, a receptor-selective topical retinoid. Br J Dermatol. 1999;141:177.
25. Tzaneva S, Hönigsmann H, Tanew A, Seeber A. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis. Br J Dermatol. 2002;147:748-53.
26. Koo JY, Lowe NJ, Lew-Kaya DA, Vasilopoulos AI, Lue JC, Sefton J, et al. Tazarotene plus UVB phototherapy in the treatment of psoriasis. J Am Acad Dermatol. 2000;43:821-8.
27. Guenther LC. Optimizing treatment with topical tazarotene. Am J Clin Dermatol. 2003;4:197-202.
28. Paul C, Gallini A, Archier E, Castela E, Devaux S, Aractingi S, et al. Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol. 2012;26(Suppl.3):1-10.
29. Schiener R, Behrens-Williams SC, Pillekamp H, Kaskel P, Peter RU, Kerscher M. Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): Efficacy in patients with severe psoriasis. Br J Dermatol. 2000;143:1275-8.
30. Rogers C. Calcipotriol (Dovobet) ointment in combination with UVB therapy for psoriasis treatment. Dermatol Nurs Dermatol Nurses Assoc. 2006;18:258-61.
31. Arechalde A, Saurat JH. Management of psoriasis: The position of retinoid drugs. BioDrugs Clin Immunother Biopharm Gene Ther. 2000;13(5):327-33. Encontré: BioDrugs. 2000;13:327-33.
32. Spuls PI, Rozenblit M, Lebwohl M. Retrospective study of the efficacy of narrowband UVB and acitretin. J Dermatol Treat. 2003;14(Suppl.2):17-20.
33. Ghasri P, Yentzer BA, Dabade TS, Feldman SR. Acitretin for the treatment of psoriasis: An assessment of national trends. J Drugs Dermatol. 2011;10:873-7.
34. Dunn LK, Gaar LR, Yentzer BA, O’Neill JL, Feldman SR. Acitretin in dermatology: A review. J Drugs Dermatol. 2011;10:772-82.
35. Hodulik SG, Zeichner JA. Combination therapy with acitretin for psoriasis. J Dermatol Treat. 2006;17:108-11.
36. Mortazavi H, Khezri S, Hosseini H, Khezri F, Vasigh M. A single blind randomized clinical study: The efficacy of isotretinoin plus narrow band ultraviolet B in the treatment of psoriasis vulgaris. Photodermatol Photoimmunol Photomed. 2011;27:159-61.
37. Ormerod AD, Campalani E, Goodfield MJD, BAD Clinical Standards Unit. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol. 2010;162:952-63.
38. De Mozzi P, Johnston GA, Alexandroff AB. Psoriasis: An evidence-based update. Br J Dermatol. 2012;166:252-60.
39. Patel RV, Clark LN, Lebwohl M, Weinberg JM. Treatments for psoriasis and the risk of malignancy. J Am Acad Dermatol. 2009;60:1001-17.
40. Warren RB, Griffiths CEM. Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine. Clin Dermatol. 2008;26:438-47.
41. Jensen P, Skov L, Zachariae C. Systemic combination treatment for psoriasis: A review. Acta Derm Venereol. 2010;90:341-9.
42. Shehzad T, Dar NR, Zakria M. Efficacy of concomitant use of PUVA and methotrexate in disease clearance time in plaque type psoriasis. J Pak Med Assoc. 2004;54:453-5.
43. Mahajan R, Kaur I, Kanwar AJ. Methotrexate/narrowband UVB phototherapy combination vs. narrowband UVB phototherapy in the treatment of chronic plaque-type psoriasis--a randomized single-blinded placebo-controlled study. J Eur Acad Dermatol Venereol. 2010;24:595-600.
44. Asawanonda P, Nateetongrungsak Y. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: A randomized, placebo-controlled study. J Am Acad Dermatol. 2006;54:1013-8.
45. Barrios M, Beltrán A, Catellanos H, Cortés C. Guías basadas en la evidencia para el manejo de la psoriasis en Colombia. Bogotá: Asociación Colombiana de Dermatología y Cirugía Dermatológica; 2012.
46. Chalela JG, González C, Castro L. Guías de manejo de psoriasis consenso colombiano. Bogotá: Asociación Colombiana de Dermatología y Cirugía Dermatológica; 2008.
47. Echeverri MA, Aristizábal AM, Vargas F, Molina JF, Pinto LF, Zuluaga Á. Nuevos avances de la terapia biológica en la psoriasis. Med Cutan Iber Lat Am. 2005;33:7-17.
48. Wolf P, Hofer A, Weger W, Posch-Fabian T, Gruber-Wackernagel A, Legat FJ. 311 nm ultraviolet B-accelerated response of psoriatic lesions in adalimumab-treated patients. Photodermatol Photoimmunol Photomed. 2011;27:186-9.
49. Bagel J. Adalimumab plus narrowband ultraviolet B light phototherapy for the treatment of moderate to severe psoriasis. J Drugs Dermatol. 2011;10:366-71.
50. Garber C, Creighton M, Sorensen E, Dumont N, Gottlieb AB. Systemic treatment of recalcitrant pediatric psoriasis: A case series and literature review. J Drugs Dermatol. 2015;14:881-6.
51. Famenini S, Wu JJ. Combination therapy with tumor necrosis factor inhibitors in psoriasis treatment. Cutis. 2013;92:140-7.
52. Scheinfeld N. Therapy resistant psoriasis treated with alefacept and subsecuent narrow band ultraviolet B phototherapy with total clearing of psoriasis. Dermatol Online J. 2005;11:7-11.
53. Koo J, Bagel J, Sweetser M, Ticho B. Alefacept in combination with ultraviolet B phototherapy for the treatment of chronic plaque psoriasis: Resulst from an open label, multicenter study. J Drugs Dermatol. 2006;5:623-8.
54. Bailey EE, Ference EH, Alikhan A, Hession MT, Armstrong AW. Combination treatments for psoriasis: A systematic review and meta-analysis. Arch Dermatol. 2012;148:511-22.
55. Menter A, Gottlieb A, Feldman SR, van Voorhees AS, Leonardi CL, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58:826-50.
56. Foley P, Quirk C, Sullivan J, Dolianitis C, Hack SP, Thirunavukkarasu K, et al. Combining etanercept with traditional agents in the treatment of psoriasis: A review of the clinical evidence. J Eur Acad Dermatol Venereol. 2010;24:1135-43.
57. Chien AL, Elder JT, Ellis CN. Ustekinumab. A new option in psoriasis therapy. Drugs. 2009;69:1141-52.
58. Wolf P, Weger W, Legat FJ, Posch-Fabian T, Gruber-Wackernagel A, Inzinger M, et al. Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: A randomized intraindividual trial. Br J Dermatol. 2012;166 :147-53.
Cómo citar
1.
Acosta LT, Gaviria CM, Giraldo AP, Mariaca J, Montes M, Jiménez SB. Fototerapia en combinación con otras terapias en psoriasis. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de diciembre de 2016 [citado 18 de abril de 2024];24(4):264-76. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/290
Descargas
Los datos de descargas todavía no están disponibles.
Descargas
Publicado
2016-12-01
Cómo citar
1.
Acosta LT, Gaviria CM, Giraldo AP, Mariaca J, Montes M, Jiménez SB. Fototerapia en combinación con otras terapias en psoriasis. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de diciembre de 2016 [citado 18 de abril de 2024];24(4):264-76. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/290
Número
Sección
Artículo de revisión
